Cipla in talks to add new customers for its China factory, executive says

SHANGHAI – Indian drugmaker Cipla (CIPL.NS), opens new tab is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to work around constrained production capacity in India, a senior executive told Reuters.

India’s third-largest drugmaker by sales started operations at its factory making inhalation respule products, opens new tabin Jiangsu province, eastern China, in 2024 to supply the U.S. market.

“Sometimes we face capacity restrictions … so they (customers) do approach us whether we can handle the supplies,” Deepak Hegde, Cipla’s general manager for China, told Reuters.

He said the company was in talks with “at least two or three different countries”, for product shipments from China and those discussions began around six or eight months ago.

He declined to say how much it had supplied to the United States from the Chinese manufacturing site or name the other countries it was in discussions with.

The Chinese site can produce about 55 million units annually of products used in inhalers, Hegde said.

Related Posts

  • Pharma
  • July 24, 2025
  • 151 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 236 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra